"Hyperkalemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Descriptor ID |
D006947
|
| MeSH Number(s) |
C18.452.950.396
|
| Concept/Terms |
Hyperkalemia- Hyperkalemia
- Hyperkalemias
- Hyperpotassemia
- Hyperpotassemias
|
Below are MeSH descriptors whose meaning is more general than "Hyperkalemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperkalemia".
This graph shows the total number of publications written about "Hyperkalemia" by people in this website by year, and whether "Hyperkalemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 3 | 0 | 3 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperkalemia" by people in Profiles.
-
Stickle DF, Koob KR, McCudden CR. Characterizing ability of serum potassium (K) and the serum K reference interval to flag hypokalemia or hyperkalemia as observed in plasma: A simulation study. Clin Biochem. 2023 Aug; 118:110606.
-
An J, Zhou H, Ni L, Harrision TN, Wei R, Agiro A, Brahmbhatt YG, Oluwatosin Y, Schilling CG, Sim JJ. Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes. Am J Nephrol. 2023; 54(7-8):258-267.
-
Pollack CV, Agiro A, Mu F, Cook EE, Lemus Wirtz E, Young JA, Betts KA, Brahmbhatt YG. Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study. Expert Rev Pharmacoecon Outcomes Res. 2023 Feb; 23(2):241-250.
-
Drumheller BC, Tuffy E, Gibney F, Stallard S, Siewers C, Korvek S. Severe bradycardia from severe hyperkalemia: Patient characteristics, outcomes and factors associated with hemodynamic support. Am J Emerg Med. 2022 05; 55:117-125.
-
Agiro A, Duling I, Eudicone J, Davis J, Brahmbhatt YG, Cooper K. The prevalence of predialysis hyperkalemia and associated characteristics among hemodialysis patients: The RE-UTILIZE study. Hemodial Int. 2022 07; 26(3):397-407.
-
Qin L, Zhang N, Ishigami J, Miller ER, Pfister M, Moran AE, Cox E. Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations. J Hum Hypertens. 2022 11; 36(11):989-995.
-
Turban S, Juraschek SP, Miller ER, Anderson CAM, White K, Charleston J, Appel LJ. Randomized Trial on the Effects of Dietary Potassium on Blood Pressure and Serum Potassium Levels in Adults with Chronic Kidney Disease. Nutrients. 2021 Jul 31; 13(8).
-
Hamrahian SM, F?l?p T. Hyperkalemia and Hypertension Post Organ Transplantation - A Management Challenge. Am J Med Sci. 2021 01; 361(1):106-110.
-
Yoon U, Gerney G, Hsu G, Elia E, Kang Y. Exchange Autotransfusion for Rapid Correction of Hyperkalemia During Liver Transplantation: A Case Report. A A Pract. 2019 Jan 01; 12(1):15-18.
-
Karaboyas A, Xu H, Morgenstern H, Locatelli F, Jadoul M, Nitta K, Dasgupta I, Tentori F, Port FK, Robinson BM. DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients. Kidney Int. 2018 09; 94(3):589-598.